
TJX (TJX) delivered earnings and revenue surprises of +3.39% and +0.29%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

TJX (TJX) delivered earnings and revenue surprises of +3.39% and +0.29%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

TJX raised its full-year profit outlook after reporting higher second-quarter sales and earnings, as more budget-leery shoppers continued to flock to its banners for discounted home goods and apparel.

A Chinese robotics IPO just attracted demand so extreme it raises a question every investor in physical AI needs to answer: are the stocks pricing in a revolution that still runs on manufacturing timelines, not software speed?

The study will run into 2028, testing two low doses of Wegovy, and follows the company disclosing recently that uptake of the pill had been particularly strong for its lowest doses across self-paying patients.

The defense contractor Lyntris sold 17 million shares in its IPO. The stock will begin trading on Wednesday.

Moby summary of Keysight Technologies, Inc.'s Q3 2026 earnings call
(Updates with store growth outlook in penultimate paragraph, and recent stock move in last paragraph

Eagle Point Credit Management LLC is providing a roughly $1.3 billion private credit loan for a sprawling AI data center in Texas tied to Anthropic PBC, giving the investment firm a key role in one of the latest jumbo financings fueling the artificial intelligence boom.

AI cloud provider Nebius Group said on Wednesday it plans to raise $4.5 billion through an offering of private convertible notes, as it seeks to ramp up investments in data centers and computing capacity. • Proceeds from the offering will be used to expand data center capacity, invest in the company's full-stack AI cloud platform and acquire GPUs and other key components needed to support growth. • Nebius shares were down more than 7% in premarket trading.

These healthcare companies can actually benefit from inflation.
US equity futures were mostly flat pre-bell Wednesday as traders awaited the Federal Reserve's polic

The semiconductor company reported higher profit and revenue in its third quarter driven by accelerating demand for data center hardware and industrial chips.
TJX Companies (TJX) reported fiscal Q2 earnings Wednesday of $1.36 per diluted share, up $1.10 from

Ding, dong. And good morning. Wall Street is limping toward the midpoint of a rough week, and Wednesday is not offering much of a hand up. Futures for the Dow and S&P 500 are loitering around the flat line, while the Nasdaq-100 is nudging slightly higher. Nobody looks in a hurry to...

The home improvement retailer cut its full-year sales and profit targets to the bottom of prior guidance ranges, citing persistent softness in do-it-yourself spending

By Rishika Sadam and Sai Ishwarbharath B Aug 19 (Reuters) - U.S. financial services firm Charles Schwab plans to expand the workforce at its newly opened India-based global capability centre to about

This single data point is also crucial to the company's long-term investment thesis.

A federal trial against Meta Platforms is putting the company’s approach to child safety and data practices under scrutiny, as plaintiffs argue that its platforms were designed in ways that harmed young users. The case is one of the most significant tests yet of how courts and regulators evaluate responsibility for the design of large consumer platforms. For cybersecurity and privacy leaders, the case highlights how data governance risks are evolving.
Bank of America Corp. has hired two more managing directors as it builds out its technology practice, according to an internal memo reviewed by Bloomberg News.

An experimental mRNA-based vaccine succeeded in preventing cancer from coming back or spreading in a study of high-risk melanoma patients, Moderna and its partner Merck said. Shares in Moderna jumped about 10% premarket, while Merck also climbed around 6%.

Result in high-risk patients validates decades of research into mRNA-based therapeutic cancer vaccines.

Plus: Disney sues FCC over license review, and Europe’s rivers are drying up, threatening its economy.

U.S. stock futures are muted with investors focused on retailer earnings and minutes from the Fed’s July meeting.

The Estee Lauder Companies narrowed its fiscal fourth-quarter loss on higher sales, as the company’s turnaround continued to pick up steam.

On the heels of a positive quarter, the retailer now expects sales growth of about 5% this fiscal year.

Target reported its second straight quarter of comparable sales gains on Wednesday, saying a merchandising overhaul under the retailer's new CEO is attracting more customers and boosting sales throughout its stores. Comparable sales — those coming from stores and digital channels operating for at least 12 months —rose 3.8% in the second quarter. Target is emerging from more than a year of weak or declining comparable sales.

Lowe’s lowered its expectations for 2026 as persistent softness in DIY spending is expected to continue to weigh on sales and earnings for the rest of the year.

Find insight on Hong Kong Exchanges & Clearing and more in the latest Market Talks covering financial services.
(Updates with Federal Communications Commission response in the fourth paragraph.) Walt Disney (D
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.